Policy progress for physician treatment of opiate addiction. - Wikidata - awgldk - TriplyDB

Policy progress for physician treatment of opiate addiction.

Policy progress for physician treatment of opiate addiction.

http://www.wikidata.org/entity/Q34743036

about

Internal medicine residents' training in substance use disorders: a survey of the quality of instruction and residents' self-perceived preparedness to diagnose and treat addiction.The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.Methadone medical maintenance in primary care. An implementation evaluation.Is primary care providers' trust in socially marginalized patients affected by race?How primary care providers talk to patients about alcohol: a qualitative study Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.Provider satisfaction with office-based treatment of opioid dependence: a systematic review.The medical management of opioid dependence in HIV primary care settings.Characteristics of methadone maintenance treatment patients prescribed opioid analgesics Providers' experiences treating chronic pain among opioid-dependent drug users.Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.Evidence for substance abuse services and policy research: a systematic review of national databases.Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand.Substance abuse: the expanding role of general internal medicine.Integrating medical care and addiction treatment An ECG-based cardiac safety initiative is well received by opioid treatment program staff: results from a qualitative assessment.Methadone dosage and retention: an examination of the 60 mg/day threshold.National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.

P2860

Q30219816-C4271298-5884-4E36-A225-175C7C753B8D Q34050760-FE6EA61C-6912-47A3-950E-BC1CD68124A2 Q34485532-A86CA69C-C60D-424C-8A15-E2B397B74A88 Q34722914-A0691F42-3484-4635-8D0C-68BA128AE90D Q35113211-985E2CF1-E0FB-4492-BC30-50A6BCA9F3E9 Q35695929-D7C12C37-1ECC-40CF-A1DD-71B0E4DC17AA Q36090286-65B1827C-08BD-427E-8CCC-3A5C4483265B Q36402982-D07B4969-B19B-4323-BCC1-8D8336DDE22A Q36646958-7944EC36-304B-4756-88A8-209D8D1424BC Q37072133-7C915877-0405-409A-B591-130756041F55 Q37136642-E5FA50F7-33B8-4CD7-A941-9164979A2D90 Q37281750-6763F62F-4D2C-49D5-A0AB-51CEFF34BA06 Q37363627-C4917FAB-4460-43A0-AD53-CE25A6D9927B Q41081367-4B725BE8-37F8-47B4-8B13-6A2FE187FEB0 Q42348090-479EDBA9-587D-4611-B94B-7863C9E4321C Q42348980-123A86C7-FCD4-45B6-8427-98952DC1E809 Q44342467-E5617FDD-69E0-41FE-A25B-D3DB421C2BB1 Q46722141-423616D4-55C1-4746-8BC2-DA3C2F75A3F7 Q55715252-12182D1D-D4FD-485D-888F-33C5A5A9A979

P2860

Policy progress for physician treatment of opiate addiction.

http://www.wikidata.org/entity/Q34743036

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Policy progress for physician treatment of opiate addiction.

@ast

Policy progress for physician treatment of opiate addiction.

@en

Policy progress for physician treatment of opiate addiction.

@nl

type

label

Policy progress for physician treatment of opiate addiction.

@ast

Policy progress for physician treatment of opiate addiction.

@en

Policy progress for physician treatment of opiate addiction.

@nl

prefLabel

Policy progress for physician treatment of opiate addiction.

@ast

Policy progress for physician treatment of opiate addiction.

@en

Policy progress for physician treatment of opiate addiction.

@nl

P1433

Q34743036-2A67E99F-3DBF-45F4-AB48-542E922260C8

P1476

Q34743036-8CAE288B-E3E6-4E52-B67D-9039C4DB1ADA

P2093

Q34743036-9C124022-87F1-481C-B36D-18843437B799

P2860

Q34743036-07C9F98E-4D50-4551-B296-1ED5BD136EFC

Q34743036-0E8431B8-7FD7-43D7-862B-6576DE97EB90

Q34743036-0EEF9F0F-1B41-452A-8A02-044D52B65C8E

Q34743036-0F616354-B410-46EE-A9EC-9FA95BBA206C

Q34743036-123DDA40-CD46-45BE-99C4-9ECDCBE5E70B

Q34743036-14DD2E41-EDA9-422F-B9E5-63D5EB13007D

Q34743036-15076F1B-3186-4C11-879C-C44318429955

Q34743036-18DC7326-78C3-4A75-AE7A-43E9B52074BD

Q34743036-27394BD4-3C49-4AD6-9DF4-1197CF47A3DC

Q34743036-2A54FD8E-8456-45A5-91B9-1DC68C0AC820

P2888

Q34743036-4A338C8A-688B-4DF2-B2C0-86F5A5B3F45B

P304

Q34743036-B90529C5-404A-49C4-B93B-7B39FE622C22

P31

Q34743036-6AA056D1-F9C0-4032-B348-E575E81B1F74

P356

Q34743036-C0375245-0F97-49BA-8184-88C7F9D6B848

P433

Q34743036-9D6734D0-D4D7-481C-A4C7-5B45D7633900

P478

Q34743036-B8F4F576-DA4E-4863-B17A-2F15A536891A

P577

Q34743036-B5280086-57A4-4EFA-AD46-7024195608E3

P6179

Q34743036-6C272B0E-2946-4044-B2F7-55972A8CAA97

P698

Q34743036-A2C8F44E-E966-49CA-A851-2309D0CBB278

P932

Q34743036-DED8E70D-9572-440E-AD3A-000DA66C6A2B

P356

S11606-002-0041-6

P1433

Journal of General Internal Medicine

P1476

Policy progress for physician treatment of opiate addiction.

@en

P2093

Joseph O Merrill

http://www.w3.org/2001/XMLSchema#string

P2860

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London.

The economic costs of heroin addiction in the United States.

Injecting misuse of buprenorphine among French drug users.

Recent developments in maintenance prescribing and monitoring in the United Kingdom.

Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

Neurobiology of addictive behaviors and its relationship to methadone maintenance.

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Creating a new drug service in Edinburgh.

P2888

s11606-002-0041-6

P304

361-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11606-002-0041-6

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022238622

http://www.w3.org/2001/XMLSchema#string

P698

12047733

http://www.w3.org/2001/XMLSchema#string

P932

1495048

http://www.w3.org/2001/XMLSchema#string